What is the recommended dosing regimen of gentamicin ear drops for an inner ear infection?

Gentamicin for Inner Ear Infection: Dosing Recommendations

For true inner ear disease (Ménière's disease with intractable vertigo), inject 0.4-0.8 mL of gentamicin solution into the middle ear space via transtympanic injection, repeated every 3-7 days for up to 3-4 sessions depending on clinical response 1.

Critical Clarification: Inner Ear vs. External/Middle Ear

First, I need to address a fundamental issue: true "inner ear infections" requiring gentamicin are extremely rare. The evidence overwhelmingly addresses:

• Ménière's disease (inner ear disorder with vertigo) - treated with intratympanic gentamicin
• External otitis or chronic suppurative otitis media - treated with topical gentamicin drops

The FDA-labeled gentamicin otic preparations 2 are for veterinary use only and should not guide human dosing.

For Ménière's Disease (Inner Ear Vestibular Disorder)

Intratympanic (Transtympanic) Injection Protocol:

• Volume: 0.4-0.8 mL per injection 1
• Frequency: Every 3-7 days 1
• Number of sessions: Up to 3-4 treatments based on vertigo control 1
• Concentration: While the guideline doesn't specify, research suggests 40 mg/mL for ablative effect, though 10-12 mg/mL may provide better hearing preservation 3, 4

Expected Outcomes:

• Vertigo control: 70-87% complete control 1
• Hearing loss risk: 12.5-15.4% 1
• Profound hearing loss: 6.6% across all delivery methods 1

Critical Contraindications:

• Contralateral vestibular disease or hypofunction 1
• Known aminoglycoside hypersensitivity 1

For External Ear Canal Infections (NOT Inner Ear)

If you're actually treating external otitis or chronic suppurative otitis media:

• Gentamicin drops are NOT first-line - ciprofloxacin shows 88% cure rate vs. only 30% for gentamicin 5
• If using gentamicin drops: Apply twice daily (not the outdated four-times-daily regimen), as antibacterial activity lasts 12 hours 6
• Major caveat: Topical gentamicin for prolonged periods (6-12 weeks) causes hearing loss in 100% of patients 7

Important Clinical Pitfalls

1. Don't confuse middle ear delivery with topical drops - intratympanic injection for Ménière's requires injection through the tympanic membrane, not simply dropping medication in the ear canal

2. Endolymphatic hydrops reduces drug penetration - patients with more severe hydrops may have lower perilymph gentamicin concentrations, potentially requiring adjusted dosing 8

3. Hearing preservation requires careful dosing - titration methods achieve 81.7% vertigo control 1, while low-dose continuous infusion (10 mg/mL at 5 μL/hour for 10 days via microcatheter) preserves hearing in 77% 4

4. The cochlea is at highest risk after 6 days of treatment 9 - monitor closely if extending therapy

Algorithm for Decision-Making

If patient has:

• Intractable vertigo from Ménière's disease unresponsive to medical therapy → Intratympanic gentamicin 0.4-0.8 mL every 3-7 days 1
• External ear canal infection → Use ciprofloxacin drops instead 5
• Chronic suppurative otitis media → Avoid gentamicin; use ciprofloxacin 5